Edition:
United States

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
13 Dec 2017
Change (% chg)

$-0.01 (-3.57%)
Prev Close
$0.35
Open
$0.37
Day's High
$0.37
Day's Low
$0.32
Volume
127,845
Avg. Vol
191,987
52-wk High
$2.06
52-wk Low
$0.32

Select another date:

Wed, Dec 13 2017

BRIEF-Contravir Pharmaceuticals adjourns annual meeting of stockholders until Dec 21

* CONTRAVIR PHARMACEUTICALS ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL DECEMBER 21, 2017

BRIEF-Contravir Pharmaceuticals enters research collaboration with Li Ka Shing Institute of Virology

* Contravir Pharmaceuticals announces research collaboration agreement with Li Ka Shing Institute of Virology Source text for Eikon: Further company coverage: (Reporting by Sruthi Ramakrishnan)

BRIEF-Contravir Pharmaceuticals receives HBV IND approval for tenofovir exalidex in the U.S.

* Contravir Pharmaceuticals receives hbv ind approval for tenofovir exalidex (txl™) in the United States

BRIEF-U.K. accepts Contravir Pharma's clinical trial application

* Contravir Pharmaceuticals announces acceptance of clinical trial application in the United Kingdom

BRIEF-ContraVir Pharmaceuticals announces issuance of new U.S. patent for expansion of cyclophilin inhibitor program

* ContraVir Pharmaceuticals announces issuance of new US patent for expansion of cyclophilin inhibitor program

Select another date: